Williams et al. J. Infect. Dis. 1994 170:946-54.* |
Sher et al. J. Immunol. 147:2713-2716, Oct. 15, 1991.* |
Fenderson et al. J. Exp. Med. 160: 1591, 1984.* |
Kitamura et al. PNAS 91:12957, 1991.* |
Tyrrell, David et al. (1991) “Structural Requirements For The Carbohydrate Ligand of E-Selectin” Proc. Natl. Acad. Sci. USA, vol. 88, pp. 10372-10376. |
Berg, E. L. et al., “Comparison of L-Selectin and E-Selectin Ligand Specificities: The L-Selectin Can Bind the E-Selectin Ligands Sialyl Lex and Sialyl Lea”, Biochemical and Biophysical Research Communications, vol. 184, No. 2, pp. 1048-1055 (1992). |
Fortune, F. et al., “The Expression of Carbohydrate Antigens in Activated T Cells and in Autoimmune Diseases”, Scand. J. Immunol., vol. 40, pp. 636-642 (1994). |
Foxall, C. et al., “The Three Members of the Selectin Receptor Family Recognize a Common Carbohydrate Epitope, the Sialyl Lewisx Oligosaccharide”, Journal of Cell Biology, vol. 17, No. 4, pp. 895-902 (1992). |
Hakomori, S.-I. “Lex and Related Structures as Adhesion Molecules”, Histochemical Journal, vol. 24, pp. 771-776 (1992). |
Halpern, M.T. et al., “Modulation of a Human Immunosuppressive Lymphokine by Monosaccarides”, Cellular Immunology, vol. 136, pp. 29-40 (1991). |
Harn, D. A. et al., “Regulation of CD430 T-Cell Subsets in Schistosomiasis: Specific Oligosaccharides Stimulate B22030 Spleen Cells to Proliferate and Secrete IL-10 and Also are Responsible for Recruitment of Peritoneal B-1 Cells”, Abstract for 11th Annual Meharry Medical College Symposium, (Apr. 4, 1994). |
Harn, D. A. et al., “LNFPIII Elevates B-1 Cells in the Peritoneal Cavity and May Indirectly Regulate CD430 T-Cells”, The FASEB Journal, vol. 8, No. 4, Abstract 2725 (1994). |
Kageshita, T. et al., “Association Between Sialyl Lewisa Expression and Tumor Progression in Melanoma”, Cancer Research, vol. 55, No. 8, pp. 1748-1751 (1995). |
Kitamura, K. et al., “Specificity Analysis of Blood Group Lewis-y (Ley) Antibodies Generated Against Synthetic and Natural Ley Determinants”, Proc. Natl. Acad. Sci. USA, vol. 91, pp. 12957-12961 (1994). |
Ko, A. I. et al., “A Schistosoma Mansoni Epitope Recognized by a Protective Monoclonal Antibody is Identical to the Stage-Specific Embryonic Antigen 1”, Proc. Natl. Acad. Sci., USA, vol. 87, pp. 4159-4163 (1990). |
Kokai, M. et al., “Elevated Ley Antigen Expression on T-Lymphocytes in Schizophrenic Patients”, Eur Arch Psychiatry Clin Neurosci, vol. 243, pp. 82-86 (1993). |
Kuchroo, V. K. et al., “B7-1 and B7-2 Costimulatory Molecules Activate Differentially the Th1/Th2 Developmental Pathways: Application to Autoimmune Disease Therapy”, Cell, vol. 80, pp. 707-718 (1995). |
Martensson, S. et al., “Sialyl-Lewisx and Related Carbohydrate Antigens in the Prostate”, Hum Pathol., vol. 26, pp. 735-739 (1995). |
Muguruma, M. et al., “Hepatic Neoexpression and Increased Plasma Levels of Lewis Y, a Carbohydrate Antigen, in Chronic Inflammatory Liver Diseases”, Am J. Clin Pathol, vol. 102, pp. 176-181 (1994). |
Ohta, S. et al.,“Tumor-Associated Glycoantigen, Sialyl Lewisa as a Target for Bispecific Antibody-Directed Adoptive Tumor Immunotherapy”, Immunology Letters, vol. 44, pp. 35-40 (1995). |
Okada, Y. et al., “Neoexpression of Sialyl Oligomeric Lewis X by Kupffer Cells in Chronic Hepatitis”, Lancet, vol. 335, pp. 1302-1306 (1990). |
Paavonen, T., et al., “Selective Expression of Sialyl-Lewis X and Lewis A Epitopes, Putative Ligands for L-Selectin, on Peripheral Lymph-Node High Endothelial Venules”, American Journal of Pathology, vol. 141, No. 6, pp. 1259-1264 (1992). |
Ryan, C. A., “Oligosaccharide Signals: From Plant Defense to Parasite Offense”, Proc. Natl. Acad. Sci. USA, vol. 91, pp. 1-2 (1994). |
Van Dam, G. J. et al., “The Immunologically Reactive O-Linked Polysaccharide Chains Derived from Circulating Cathodic Antigen Isolated from the Human Blood Fluke Schistosoma Mansoni have Lewis x as Repeating Unit”, Eur. J. Biochem., vol. 225, pp. 467-482 (1994). |
Velupillai, P. et al., “Oligosaccharide Interactions with Mononuclear Cells from Mice Infected with Schistosoma Mansoni or Trypanosoma Cruzi May Lead to CD430 T Cell Subset Regulation”, Abstract for Am. Soc. of Tropical Medicine and Hygiene Meeting (Nov. 1993). |
Velupillai, P. et al., “Recombinant Murine IL-12 Inhibits Ligand-Specific Recruitment of Peritoneal B22030 , CD530 (B-1) Cells”, Abstract for Clinical Immunology Meeting (Apr. 1994). |
Velupillai, P. et al., “Oligosaccharide-Specific Induction of Interleukin 10 Production by B22030 Cells from Schistosome-Infected Mice: A Mechanism for Regulation of CD430 T-Cell Subsets”, Proc. Natl. Acad. Sci. USA, vol. 91, pp. 18-22 (1994). |
Velupillai, P., et al., “Interleukin-12 and—10 and Gamma Interferon Regulate Polyclonal and Ligand-Specific Expansion of Murine B-1 Cells”, Infection and Immunity, vol. 64, No. 11, pp. 4557-4560 (1996). |